Literature DB >> 34046804

Invasive Streptococcus pyogenes disease in Spain: a microbiological and epidemiological study covering the period 2007-2019.

Pilar Villalón1, Juan A Sáez-Nieto2, Virginia Rubio-López2, María José Medina-Pascual2, Noelia Garrido2, Gema Carrasco2, Silvia Pino-Rosa2, Sylvia Valdezate2.   

Abstract

The aim of this study is to present the first nationwide microbiological and epidemiological study of invasive group A Streptococcus (iGAS) disease in Spain. One thousand eight hundred ninety-three iGAS isolates were analyzed over 2007-2019. emm typing was performed by sequencing the gene's variable 5' end, exotoxin genes were identified by PCR, and antimicrobial susceptibility explored via the E test and disk diffusion. Five hundred twenty-three isolates were associated with sepsis, 292 with cellulitis, 232 with scarlet fever, 153 with pneumonia, 141 with streptococcal toxic shock syndrome, and 94 with necrotizing fasciitis. The most prevalent emm types were emm1 (449/1893 isolates), emm89 (210/1893), emm3 (208/1893), emm4 (150/1893), emm12 (112/1893) emm6 (107/1893), emm87 (89/1893), emm28 (88/1893), emm75 (78/1893), emm77 (78/1893), emm11 (58/1893), and emm22 (35/1893). emm1, emm3, emm4, and emm6 were the predominant types affecting children (mostly respiratory infections), while emm11, emm77, and emm89 prevailed in the elderly (mostly skin infections). Each emm type was associated with one or more exotoxin gene (spe, sme, and ssa) profiles. speA was detected in 660 isolates, speB in 1829, speC in 1014, speF in 1826, speG in 1651, speJ in 716, speH in 331, smeZ in 720, and ssa in 512. Isolates with speA were associated with the most severe infections. Penicillin susceptibility was universal. Two hundred twenty-four isolates were resistant to tetracycline, 169 to erythromycin, and 81 to clindamycin. Tetracycline, erythromycin, and clindamycin resistance rates declined over the study period. The above information could serve as the basis for continued surveillance efforts designed to control disease cause by this bacterium.
© 2021. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  : Streptococcus pyogenes; Antimicrobial resistance; Exotoxins; Invasive disease; Surveillance; emm typing

Mesh:

Substances:

Year:  2021        PMID: 34046804     DOI: 10.1007/s10096-021-04279-2

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  30 in total

Review 1.  The streptococcal M protein: a highly versatile molecule.

Authors:  Pierre R Smeesters; David J McMillan; Kadaba S Sriprakash
Journal:  Trends Microbiol       Date:  2010-03-27       Impact factor: 17.079

Review 2.  Molecular epidemiology and genomics of group A Streptococcus.

Authors:  Debra E Bessen; W Michael McShan; Scott V Nguyen; Amol Shetty; Sonia Agrawal; Hervé Tettelin
Journal:  Infect Genet Evol       Date:  2014-10-30       Impact factor: 3.342

3.  Evolutionary origin and emergence of a highly successful clone of serotype M1 group a Streptococcus involved multiple horizontal gene transfer events.

Authors:  Paul Sumby; Steve F Porcella; Andres G Madrigal; Kent D Barbian; Kimmo Virtaneva; Stacy M Ricklefs; Daniel E Sturdevant; Morag R Graham; Jaana Vuopio-Varkila; Nancy P Hoe; James M Musser
Journal:  J Infect Dis       Date:  2005-07-29       Impact factor: 5.226

Review 4.  Molecular basis of group A streptococcal virulence.

Authors:  A L Bisno; M O Brito; C M Collins
Journal:  Lancet Infect Dis       Date:  2003-04       Impact factor: 25.071

Review 5.  Streptococcal M protein: molecular design and biological behavior.

Authors:  V A Fischetti
Journal:  Clin Microbiol Rev       Date:  1989-07       Impact factor: 26.132

Review 6.  The global burden of group A streptococcal diseases.

Authors:  Jonathan R Carapetis; Andrew C Steer; E Kim Mulholland; Martin Weber
Journal:  Lancet Infect Dis       Date:  2005-11       Impact factor: 25.071

Review 7.  Group A streptococci in the 1990s.

Authors:  A Efstratiou
Journal:  J Antimicrob Chemother       Date:  2000-02       Impact factor: 5.790

Review 8.  Pregnancy-related group a streptococcal infections: temporal relationships between bacterial acquisition, infection onset, clinical findings, and outcome.

Authors:  Stephanie M Hamilton; Dennis L Stevens; Amy E Bryant
Journal:  Clin Infect Dis       Date:  2013-05-03       Impact factor: 9.079

Review 9.  Disease manifestations and pathogenic mechanisms of Group A Streptococcus.

Authors:  Mark J Walker; Timothy C Barnett; Jason D McArthur; Jason N Cole; Christine M Gillen; Anna Henningham; K S Sriprakash; Martina L Sanderson-Smith; Victor Nizet
Journal:  Clin Microbiol Rev       Date:  2014-04       Impact factor: 26.132

10.  Emergence of a New Highly Successful Acapsular Group A Streptococcus Clade of Genotype emm89 in the United Kingdom.

Authors:  Claire E Turner; James Abbott; Theresa Lamagni; Matthew T G Holden; Sophia David; Michael D Jones; Laurence Game; Androulla Efstratiou; Shiranee Sriskandan
Journal:  mBio       Date:  2015-07-14       Impact factor: 7.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.